Online citations, reference lists, and bibliographies.
← Back to Search

Development And Evaluation Of Buccal Films Impregnated With Selegiline-loaded Nanospheres

Bandar E Aldhubiab, Anroop B Nair, R. Kumria, M. Attimarad, S. Harsha
Published 2016 · Medicine, Materials Science

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Abstract Poor peroral therapeutic efficiency of selegiline is primarily due to the extensive hepatic metabolism and hence the need for an alternative route of administration. The present study is based on evaluation of a buccal film which is impregnated with selegiline nanospheres to enhance the systemic bioavailability. Selegiline-loaded nanospheres prepared using poly(lactide-co-glycolide) was embedded into buccal films (F1–F4) with varying polymer composition [hydroxypropyl methylcellulose and eudragit]. The developed films were evaluated for their physicomechanical properties, hydration, mucoadhesive strength, in vitro drug release and ex vivo permeation in order to identify the ideal system suitable for further development. In vivo studies were carried out on rabbits to assess the comparative pharmacokinetics profile of the selected buccal film with oral solution. Preliminary studies indicated that the prepared films exhibited excellent physical properties, adequate mucoadhesive strength and moderate hydration. In vitro drug release data of the buccal films (F1, F2 and F3) showed distinct profiles. Permeation studies indicated higher steady-state flux from film F3 (p < 0.0001) when compared to film F2. In-vivo results of film (F3) demonstrated significant increase in absorption (p < 0.0001), Cmax (∼1.6-fold), Tmax, AUC0–α (∼3-fold, p < 0.0001) and improved bioavailability, when compared to control. This study concludes that the buccal delivery of selegiline using the developed buccal film (F3) would be a promising alternative approach for the treatment of Parkinson's disease.
This paper references
Parkinson's disease: health-related quality of life, economic cost, and implications of early treatment.
J. Chen (2010)
10.1016/j.jconrel.2012.11.019
In vitro techniques to evaluate buccal films.
Anroop B Nair (2013)
10.2165/00003088-199630060-00004
Pharmacokinetic Optimisation in the Treatment of Parkinson’s Disease
M. Contin (1996)
10.1007/s00455-008-9180-1
Effects of Therapy for Dysphagia in Parkinson’s Disease: Systematic Review
L. Baijens (2008)
10.2165/00003495-200767020-00006
Selegiline Transdermal System In the Treatment of Major Depressive Disorder
J. Frampton (2012)
10.1016/j.ijpharm.2012.02.035
Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): a potential approach for buccal delivery of macromolecules.
Concetta Giovino (2012)
10.1016/J.JCONREL.2007.03.012
Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody.
P. Kocbek (2007)
10.3109/10717544.2014.920058
Buccal films of prednisolone with enhanced bioavailability
R. Kumria (2016)
10.3949/ccjm.77a.09103
MAO inhibitors: Risks, benefits, and lore
Molly Wimbiscus (2010)
10.3109/10717544.2013.876459
Mucoadhesive buccal films containing phospholipid-bile salts-mixed micelles as an effective carrier for Cucurbitacin B delivery
Qingyuan Lv (2015)
10.1016/j.ijpharm.2011.05.060
Transdermal delivery of selegiline from alginate-Pluronic composite thermogels.
Chih-Chieh Chen (2011)
10.1002/JPS.10198
Transmucosal delivery of testosterone in rabbits using novel bi-layer mucoadhesive wax-film composite disks.
S. Jay (2002)
10.1586/ern.10.73
Development of Parkinson’s disease biomarkers
K. M. Prakash (2010)
10.1002/PSB.874
Parkinson's disease: a guide to pharmacological management
Edward Needham (2012)
10.3109/03639045.2014.884125
Loratidine buccal films for allergic rhinitis: development and evaluation
R. Kumria (2014)
Tremor-predominant Parkinson’s disease. Approaches to treatment
J Marjama-Lyons (2000)
10.1517/13543784.17.7.1115
An expert opinion on safinamide in Parkinson's disease.
M. Onofrj (2008)
10.1212/01.wnl.0000247740.47667.03
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
E. Dorsey (2007)
10.3109/10717544.2011.557786
Development of bioadhesive buccal tablets for felodipine and pioglitazone in combined dosage form: In vitro, ex vivo, and in vivo characterization
C. Palem (2011)
10.1016/j.tins.2013.06.003
Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems
Lars Brichta (2013)
10.1007/s00702-011-0703-9
Continuous drug delivery in early- and late-stage Parkinson’s disease as a strategy for avoiding dyskinesia induction and expression
Peter Jenner (2011)
10.2174/157341313805117866
Formulation and In Vitro Evaluation of Gelatin Nanospheres for the Oral Delivery of Selegiline
Bandar E Aldhubiab (2013)
10.1080/10837450701563277
In Vitro Controlled Release of Alfuzosin Hydrochloride Using HPMC-Based Matrix Tablets and Its Comparison with Marketed Product
Anroop B Nair (2007)
10.1016/j.ijpharm.2014.03.049
Chitosan lactate wafer as a platform for the buccal delivery of tizanidine HCl: in vitro and in vivo performance.
Galal M. El-Mahrouk (2014)
10.4088/JCP.V67N0905
Selegiline transdermal system for the treatment of major depressive disorder: an 8-week, double-blind, placebo-controlled, flexible-dose titration trial.
A. Feiger (2006)
10.3109/10717544.2010.520351
In vivo, in vitro evaluation of linseed mucilage based buccal mucoadhesive microspheres of venlafaxine
P. Nerkar (2011)
10.1007/s00702-003-0036-4
A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition
A. Clarke (2003)
10.1016/J.JCONREL.2006.04.012
Buccal bioadhesive drug delivery--a promising option for orally less efficient drugs.
Y. Sudhakar (2006)
10.2174/156720109788680895
Transdermal delivery of atenolol: effect of prodrugs and iontophoresis.
Anroop B Nair (2009)
10.3109/10717544.2014.896958
Design, development and characterization of buccal bioadhesive films of Doxepin for treatment of odontalgia
H. Castán (2015)
10.1007/s40263-013-0127-1
Continuous Drug Delivery in Parkinson’s Disease
M. Senek (2013)
10.3109/10717544.2013.779331
Formulation and evaluation of mucoadhesive buccal films impregnated with carvedilol nanosuspension: a potential approach for delivery of drugs having high first-pass metabolism
P. Rana (2013)
10.1212/WNL.63.7_SUPPL_2.S2
A novel formulation of selegiline for the treatment of Parkinson’s disease
J. Tetrud (2004)
10.1016/j.ijpharm.2009.06.025
Transdermal permeation of selegiline from hydrogel-membrane drug delivery systems.
Jia-You Fang (2009)
10.1016/J.JCONREL.2004.06.005
Development of mucoadhesive patches for buccal administration of ibuprofen.
L. Perioli (2004)
10.3109/10717544.2013.844744
Development and characterization of PLGA nanoparticles as delivery systems of a prodrug of zidovudine obtained by its conjugation with ursodeoxycholic acid
A. Dalpiaz (2014)
10.1001/jama.2014.3654
Pharmacological treatment of Parkinson disease: a review.
B. Connolly (2014)
10.3109/10717544.2014.917388
Controlled release effervescent buccal discs of buspirone hydrochloride: in vitro and in vivo evaluation studies
A. Jaipal (2016)



This paper is referenced by
10.5505/TJPS.2016.05706
Mucoadhesive buccal films embedded with antiviral drug loaded nanospheres
Bandar E Aldhubiab (2016)
10.2174/1570180813666160125224604
Pharmacokinetics of selegiline in a rabbit model
H. Kalász (2016)
10.3390/pharmaceutics12090893
Development and Optimization of Naringenin-Loaded Chitosan-Coated Nanoemulsion for Topical Therapy in Wound Healing
Sabah H. Akrawi (2020)
10.1016/j.colsurfb.2015.10.045
Formulation and evaluation of nano based drug delivery system for the buccal delivery of acyclovir.
Bandar E Aldhubiab (2015)
10.3390/pharmaceutics11050230
Nanoemulsion Based Vehicle for Effective Ocular Delivery of Moxifloxacin Using Experimental Design and Pharmacokinetic Study in Rabbits
Jigar Shah (2019)
10.1016/j.colsurfb.2017.12.030
Non-equilibrium atmospheric pressure plasma as innovative method to crosslink and enhance mucoadhesion of econazole-loaded gelatin films for buccal drug delivery.
L. Dolci (2018)
10.3389/fphar.2019.01328
Advances in Nanoparticulate Drug Delivery Approaches for Sublingual and Buccal Administration
Susan Hua (2019)
10.22270/jddt.v10i1-s.3790
In vivo antiplasmodial potential of Carrageenan and Prosopis africana buccal films of artemether on malariogenic mice
Po Nnamani (2020)
10.1016/j.msec.2017.12.022
An overview of polymeric dosage forms in buccal drug delivery: State of art, design of formulations and their in vivo performance evaluation.
Bruno Fonseca-Santos (2018)
10.3389/fphar.2019.01057
Pharmacokinetic Aspects of Nanoparticle-in-Matrix Drug Delivery Systems for Oral/Buccal Delivery
Renata de Carvalho Feitosa (2019)
10.3390/ma12244239
HPMC- and PLGA-Based Nanoparticles for the Mucoadhesive Delivery of Sitagliptin: Optimization and In Vivo Evaluation in Rats
Anroop B Nair (2019)
10.1016/j.ijpharm.2017.09.073
Cyanine derivative as a suitable marker for thermosensitive in situ gelling delivery systems: In vitro and in vivo validation of a sustained buccal drug delivery.
Ni Zeng (2017)
10.1080/21691401.2018.1463230
Non-invasive systemic drug delivery through mucosal routes
Amit Goyal (2018)
10.1590/1807-3107BOR-2016.vol30.0126
In vitro and in vivo evaluation of nano-based films for buccal delivery of zolpidem.
Bandar E Aldhubiab (2016)
10.3390/nu12103186
The Beneficial Effect of Boswellic Acid on Bone Metabolism and Possible Mechanisms of Action in Experimental Osteoporosis
Bandar E Aldhubiab (2020)
10.1080/1061186X.2017.1350858
Brain targeted delivery of mucoadhesive thermosensitive nasal gel of selegiline hydrochloride for treatment of Parkinson's disease
V. Sridhar (2018)
10.1016/j.jsps.2019.11.022
Mucoadhesive buccal film of almotriptan improved therapeutic delivery in rabbit model
Anroop B Nair (2020)
ON NATURAL POLYMER BASED MUCOADHESIVE BUCCAL FILMS FOR CONTROLLED DRUG DELIVERY
Ankita Khade (2019)
10.1007/s12247-018-9312-6
Formulation and Evaluation of Chitosan-Based Buccal Bioadhesive Films of Zolmitriptan
R. Kumria (2018)
10.1016/J.JDDST.2018.08.014
Development and evaluation of palonosetron loaded mucoadhesive buccal films
Anroop B Nair (2018)
10.3390/molecules24244566
Development of Asialoglycoprotein Receptor-Targeted Nanoparticles for Selective Delivery of Gemcitabine to Hepatocellular Carcinoma
Anroop B Nair (2019)
10.5530/JYP.2017.9.19
Mucoadhesive Film Embedded with Acyclovir Loaded Biopolymeric Nanoparticles: In vitro Studies
Anroop B Nair (2017)
10.3390/pharmaceutics12100920
Development of Metronidazole Loaded Chitosan Nanoparticles Using QbD Approach—A Novel and Potential Antibacterial Formulation
N. Sreeharsha (2020)
10.1016/j.ijpharm.2020.119411
Nanotechnology based blended chitosan-pectin hybrid for safe and efficient consolidative antiemetic and neuro-protective effect of meclizine hydrochloride in chemotherapy induced emesis.
A. Salama (2020)
10.1080/10837450.2019.1682608
Mucoadhesive films based on gellan gum/pectin blends as potential platform for buccal drug delivery
F. Prezotti (2019)
10.3390/app10155341
Vesicular Emulgel Based System for Transdermal Delivery of Insulin: Factorial Design and In Vivo Evaluation
Anroop B Nair (2020)
10.1016/J.JDDST.2017.12.007
Optimization and evaluation of mucoadhesive buccal films loaded with resveratrol
Mudassir Ansari (2018)
Semantic Scholar Logo Some data provided by SemanticScholar